Big Pharma Challenges FDA's New Off-Label Rule
Big Pharma is calling on the U.S. Food and Drug Administration to overhaul a newly finalized regulation giving the agency wide latitude to police off-label promotion, saying it contains abrupt and...To view the full article, register now.
Already a subscriber? Click here to view full article